Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Frydenberg

Showing results (111-120 of 182) with videos related to

Pageof 19
Sort By:
Psycho-Oncology|October 8, 2021
Self-reported lack of energy or feeling depressed 12 months after treatment in men diagnosed with prostate cancer within a population-based registryJonathan G Bensley, Haryana M Dhillon, Sue M Evans, et al.
The Journal of Urology|February 22, 2021
Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) InitiativeSophie M Bruinsma, Daan Nieboer, Monique J Roobol, et al.
Clinical Epigenetics|March 20, 2020
Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancerMitchell G Lawrence, Ruth Pidsley, Birunthi Niranjan, et al.
European Urology Oncology|October 1, 2019
Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance InitiativeArveen A Kalapara, Jan F M Verbeek, Daan Nieboer, et al.
BMJ Open|March 8, 2014
Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancerJon Emery, Juanita Doorey, Michael Jefford, et al.
BJU International|February 14, 2015
Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgeryPrassannah Satasivam, Fairleigh Reeves, Kenny Rao, et al.
International Journal of Cancer|June 20, 2024
Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trialAndrew W See, Paul Conway, Mark Frydenberg, et al.
The Medical Journal of Australia|June 4, 2013
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011Sue M Evans, Jeremy L Millar, Ian D Davis, et al.
Nature Reviews. Urology|March 9, 2016
Enhancing active surveillance of prostate cancer: the potential of exercise medicineDaniel A Galvão, Dennis R Taaffe, Nigel Spry, et al.
BMJ Open|February 3, 2022
Evaluating a multicomponent survivorship programme for men with prostate cancer in Australia: a single cohort studyPatsy Yates, Rob Carter, Robyn Cockerell, et al.
Pageof 19

Showing results (111-120 of 182) with videos related to

Sort By:
Pageof 19
Psycho-Oncology|October 8, 2021
Self-reported lack of energy or feeling depressed 12 months after treatment in men diagnosed with prostate cancer within a population-based registryJonathan G Bensley, Haryana M Dhillon, Sue M Evans, et al.
The Journal of Urology|February 22, 2021
Risk-Based Selection for Active Surveillance: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance (GAP3) InitiativeSophie M Bruinsma, Daan Nieboer, Monique J Roobol, et al.
Clinical Epigenetics|March 20, 2020
Alterations in the methylome of the stromal tumour microenvironment signal the presence and severity of prostate cancerMitchell G Lawrence, Ruth Pidsley, Birunthi Niranjan, et al.
European Urology Oncology|October 1, 2019
Adherence to Active Surveillance Protocols for Low-risk Prostate Cancer: Results of the Movember Foundation's Global Action Plan Prostate Cancer Active Surveillance InitiativeArveen A Kalapara, Jan F M Verbeek, Daan Nieboer, et al.
BMJ Open|March 8, 2014
Protocol for the ProCare Trial: a phase II randomised controlled trial of shared care for follow-up of men with prostate cancerJon Emery, Juanita Doorey, Michael Jefford, et al.
BJU International|February 14, 2015
Patients with medical risk factors for chronic kidney disease are at increased risk of renal impairment despite the use of nephron-sparing surgeryPrassannah Satasivam, Fairleigh Reeves, Kenny Rao, et al.
International Journal of Cancer|June 20, 2024
Five-year outcomes of fractionated stereotactic body radiotherapy for oligometastatic prostate cancer from the TRANSFORM phase II trialAndrew W See, Paul Conway, Mark Frydenberg, et al.
The Medical Journal of Australia|June 4, 2013
Patterns of care for men diagnosed with prostate cancer in Victoria from 2008 to 2011Sue M Evans, Jeremy L Millar, Ian D Davis, et al.
Nature Reviews. Urology|March 9, 2016
Enhancing active surveillance of prostate cancer: the potential of exercise medicineDaniel A Galvão, Dennis R Taaffe, Nigel Spry, et al.
BMJ Open|February 3, 2022
Evaluating a multicomponent survivorship programme for men with prostate cancer in Australia: a single cohort studyPatsy Yates, Rob Carter, Robyn Cockerell, et al.
Pageof 19